Kailera Therapeutics, Inc.KLRA

2 13D/G filings 2 distinct filers 0 insider transactions (365d)

1 STRATEGIC1 UNCLEAR

Cross-Reference Snapshot

Activist filings

2 SCHEDULE 13D

Distinct filers

multi-activist cluster

Insiders (365d)

0 buys · 0 sales

Latest short DTC

—

no FINRA match

Filed	Form	Filer	Stake	Shares	Intent
2026-04-23	SCHEDULE 13D	BCPE Perseus Investor, LP	20.27%	26,255,581	STRATEGIC	view →
2026-04-23	SCHEDULE 13D	BCLS Fund IV Investments, L.P.	17.43%	22,583,268	UNCLEAR	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts · full feed · daily intelligence · API. $1,500/mo. Pilots welcome.